Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF

Biochemical and Biophysical Research Communications

Volumn 339, Issue 4, 2006, Pages 1098-1106

  Takeda, Kazuhisa ^a   Yokoyama, Satoru ^a   Aburatani, Hiroyuki ^b   Masuda, Takayuki ^c   Han, Feng ^a   Yoshizawa, Miki ^a   Yamaki, Naomi ^c   Yamamoto, Hiroaki ^c   Eguchi, Naomi ^d   Urade, Yoshihiro ^d   Shibahara, Shigeki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Lipocalin type prostaglandin D synthase; Melanocyte; Melanoma; Microphthalmia associated transcription factor; Prostaglandin D2; Skin

Indexed keywords

COMPLEMENTARY DNA; LIPOCALIN; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROSTAGLANDIN D SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ANALYSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SKIN; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; GENE EXPRESSION PROFILING; INTRAMOLECULAR OXIDOREDUCTASES; MELANOCYTES; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; RETINAL GANGLION CELLS; SKIN; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 29044445875     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.125     Document Type: Article

References (46)

1. C.A. Hodgkinson, K.J. Moore, A. Nakayama, E. Steingrímsson, N.G. Copeland, N.A. Jenkins, and H. Arnheiter Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein Cell 74 1993 395 404
2. E. Steingrímsson, K.J. Moore, M.L. Lamoreux, D.A.A.R. Ferre, S.K. Burley, D.C. Zimring, L.C. Skow, C.A. Hodgkinson, H. Arnheiter, N.G. Copeland, and N.A. Jenkins Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences Nat. Genet. 8 1994 256 263
3. T.J. Hemesath, E. Steingrimsson, G. McGill, M.J. Hansen, J. Vaught, C.A. Hodgkinson, H. Arnheiter, N.G. Copeland, N.A. Jenkins, and D.E. Fisher microphthalmia, a critical factor in melanocyte development, defines a discrete transcription family Genes Dev. 8 1994 2770 2780
4. H. Saito, K. Yasumoto, K. Takeda, K. Takahashi, H. Yamamoto, and S. Shibahara Microphthalmia-associated transcription factor in the wnt signaling pathway Pigment Cell Res. 16 2003 261 265
5. A. Slominski, D.J. Tobin, S. Shibahara, and J. Wortsman Melanin pigmentation in mammalian skin and its hormonal regulation Physiol. Rev. 84 2004 1155 1228
6. M. Tachibana, L.A. Perez-Jurado, A. Nakayama, C.A. Hodgkinson, X. Li, M. Schneider, T. Miki, J. Fex, U. Francke, and H. Arnheiter Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3 Hum. Mol. Genet. 3 1994 553 557
7. M. Tassabehji, V.E. Newton, and A.P. Read Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene Nat. Genet. 8 1994 251 255
8. M. Tassabehji, V.E. Newton, X.Z. Liu, A. Brady, D. Donnai, M. Krajewska-Walasek, V. Murday, A. Norman, E. Obersztyn, W. Reardon, J.C. Rice, R. Trembath, P. Wieacker, M. Whiteford, R. Winter, and A.P. Read The mutational spectrum in Waardenburg syndrome Hum. Mol. Genet. 4 1995 2131 2137
9. Y. Nobukuni, A. Watanabe, K. Takeda, H. Skarka, and M. Tachibana Analyses of loss-of-function mutations of the MITF gene suggest that haploin sufficiency is a cause of Waardenburg syndrome type 2A Am. J. Hum. Genet. 59 1996 76 83
10. I. Aksan, and C.R. Goding Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo Mol. Cell. Biol. 18 1998 6930 6938
11. N.J. Bentley, T. Eisen, and C.R. Goding Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator Mol. Cell. Biol. 14 1994 7996 8006
12. K. Yasumoto, K. Yokoyama, K. Shibata, Y. Tomita, and S. Shibahara Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene Mol. Cell. Biol. 14 1994 8058 8070
13. K. Yasumoto, H. Mahalingam, H. Suzuki, M. Yoshizawa, K. Yokoyama, and S. Shibahara Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse Microphthalmia protein J. Biochem. (Tokyo) 118 1995 874 881
14. K. Yasumoto, K. Yokoyama, K. Takahashi, Y. Tomita, and S. Shibahara Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes J. Biol. Chem. 272 1997 503 509
15. M. Tachibana, K. Takeda, Y. Nobukuni, K. Urabe, J.E. Long, K.A. Meyers, S.A. Aaronson, and T. Miki Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics Nat. Genet. 14 1996 50 54
16. S. Amae, N. Fuse, K. Yasumoto, S. Sato, I. Yajima, H. Yamamoto, T. Udono, Y.K. Durlu, M. Tamai, K. Takahashi, and S. Shibahara Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium Biochem. Biophys. Res. Commun. 247 1998 710 715
17. N. Fuse, K. Yasumoto, K. Takeda, S. Amae, M. Yoshizawa, T. Udono, K. Takahashi, M. Tamai, Y. Tomita, M. Tachibana, and S. Shibahara Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus J. Biochem. (Tokyo) 126 1999 1043 1051
18. T. Udono, K. Yasumoto, K. Takeda, S. Amae, K. Watanabe, H. Saito, N. Fuse, M. Tachibana, K. Takahashi, M. Tamai, and S. Shibahara Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters Biochim. Biophys. Acta 1491 2000 205 219
19. K. Takeda, K. Yasumoto, N. Kawaguchi, T. Udono, K. Watanabe, H. Saito, K. Takahashi, M. Noda, and S. Shibahara Mitf-D, a newly identified isoform, expressed in the retinal pigment epithelium and monocyte-lineage cells affected by Mitf mutations Biochim. Biophys. Acta 1574 2002 15 23
20. K. Oboki, E. Morii, T.R. Kataoka, T. Jippo, and Y. Kitamura Isoforms of mi transcription factor preferentially expressed in cultured mast cells of mice Biochem. Biophys. Res. Commun. 290 2002 1250 1254
21. C.M. Takemoto, Y.J. Yoon, and D.E. Fisher The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor J. Biol. Chem. 277 2002 30244 30252
22. K. Takeda, C. Takemoto, I. Kobayashi, A. Watanabe, Y. Nobukuni, D.E. Fisher, and M. Tachibana Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance Hum. Mol. Genet. 9 2000 125 132
23. N. Fuse, K. Yasumoto, H. Suzuki, K. Takahashi, and S. Shibahara Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene Biochem. Biophys. Res. Commun. 219 1996 702 707
24. H. Motohashi, K. Hozawa, T. Oshima, T. Takeuchi, and T. Takasaka Dysgenesis of melanocytes and cochlear dysfunction in mutant microphthalmia (mi) mice Hear. Res. 80 1994 10 20
25. I. Yajima, S. Sato, T. Kimura, K. Yasumoto, S. Shibahara, C.R. Goding, and H. Yamamoto An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness Hum. Mol. Genet. 8 1999 1431 1441
26. H. Saito, K. Takeda, K. Yasumoto, H. Ohtani, K. Watanabe, K. Takahashi, A. Fukuzaki, Y. Arai, H. Yamamoto, and S. Shibahara Germ cell-specific expression of microphthalmia-associated transcription factor mRNA in mouse testis J. Biochem. (Tokyo) 134 2003 143 150
27. Y. Urade, and O. Hayaishi Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase Biochim. Biophys. Acta 1482 2000 259 271
28. C.T. Beuckmann, M. Aoyagi, I. Okazaki, T. Hiroike, H. Toh, O. Hayaishi, and Y. Urade Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase Biochemistry 38 1999 8006 8013
29. M. Ishii, S. Hashimoto, S. Tsutsumi, Y. Wada, K. Matsushima, T. Kodama, and H. Aburatani Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis Genomics 68 2000 136 143
30. D.C. Bennett, P.J. Cooper, and I.R. Hart A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth Int. J. Cancer 39 1987 414 418
31. K. Takeda, K. Yasumoto, R. Takada, S. Takada, K. Watanabe, T. Udono, H. Saito, K. Takahashi, and S. Shibahara Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a J. Biol. Chem. 275 2000 14013 14016
32. L. Ercolani, B. Florence, M. Denaro, and M. Alexander Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene J. Biol. Chem. 263 1988 15335 15341
33. M. Taniike, I. Mohri, N. Eguchi, C.T. Beuckmann, K. Suzuki, and Y. Urade Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model J. Neurosci. 22 2002 4885 4896
34. N. Eguchi, T. Minami, N. Shirafuji, Y. Kanaoka, T. Tanaka, A. Nagata, N. Yoshida, Y. Urade, S. Ito, and O. Hayashi Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice Proc. Natl. Acad. Sci. USA 96 1999 726 730
35. K. Yasumoto, K. Takeda, H. Saito, K. Watanabe, K. Takahashi, and S. Shibahara Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling EMBO J. 21 2002 2703 2714
36. H. Saito, K. Yasumoto, K. Takeda, K. Takahashi, A. Fukuzaki, S. Orikasa, and S. Shibahara Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own promoter through physical interaction with lymphoid-enhancing factor 1 J. Biol. Chem. 277 2002 28787 28794
37. S.R. Eberhardy, C.A. D'Cunha, and P.J. Farnham Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation J. Biol. Chem. 275 2000 33798 33805
38. C.S. Moreno, G.W. Beresford, P. Louis-Plence, A.C. Morris, and J.M. Boss CREB regulates MHC class II expression in a CIITA-dependent manner Immunity 10 1999 143 151
39. L.F. García-Fernández, M.A. Iñiguez, N. Eguchi, M. Fresno, Y. Urade, and A. Muñoz Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells J. Neurochem. 75 2000 460 470
40. F.A. Fitzpatrick, and D.A. Stringfellow Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential Proc. Natl. Acad. Sci. USA 76 1979 1765 1769
41. Y. Urade, M. Ujihara, Y. Horiguchi, K. Ikai, and O. Hayaishi The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues J. Immunol. 143 1989 2982 2989
42. E. Morii, and K. Oboki MITF is necessary for generation of prostaglandin D2 in mouse mast cells J. Biol. Chem. 279 2004 48923 48929
43. M.D. Bregman, and F.L. Meyskens Jr. In vitro modulation of human and murine melanoma growth by prostanoid analogues Prostaglandins 26 1983 449 456
44. B.K. Bhuyan, E.G. Adams, G.J. Badiner, L.H. Li, and K. Barden Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture Cancer Res. 46 1986 1688 1693
45. J. Kim, P. Yang, M. Suraokar, A.L. Sabichi, N.D. Llansa, G. Mendoza, V. Subbarayan, C.J. Logothetis, R.A. Newman, S.M. Lippman, and D.G. Menter Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products Cancer Res. 65 2005 6189 6198
46. P.A. Riley Melanoma and the problem of malignancy Tohoku J. Exp. Med. 204 2004 1 9